The FDA approves Gilead’s remdesivir as a coronavirus remedy

A laboratory technician shows the drug “Remdesivir” used to treat coronavirus disease (COVID-19).

Facebook Facebook Logo Log in to Facebook to connect with Amr Abdallah Dalsh Reuters

The Food and Drug Administration approved Gilead Sciences’ antiviral drug Remdesivir for the treatment of the coronavirus on Thursday.

In May, the FDA granted the drug an emergency clearance that allowed hospitals and doctors to use the drug on patients hospitalized with the disease, even though the drug was not officially approved by the agency. The intravenous drug has helped shorten the recovery time for some hospitalized Covid-19 patients.

Remdesivir is now the first and only fully approved treatment in the US for Covid-19, which has infected more than 41.3 million people and killed more than 1 million people, according to Johns Hopkins University.

“Since the beginning of the COVID-19 pandemic, Gilead has worked tirelessly to find solutions to this global health crisis,” said Daniel O’Day, CEO of Gilead, in a statement. “It is incredible today, less than a year after the earliest case reports of the disease now known as COVID-19, to be able to have an FDA-cleared treatment in the US for all eligible patients in need is available. “”

This is the latest news. Please try again.

Comments are closed.